213 related articles for article (PubMed ID: 21468002)
1. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
Shu Y; Cinier M; Fox SR; Ben-Johnathan N; Guo P
Mol Ther; 2011 Jul; 19(7):1304-11. PubMed ID: 21468002
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of specific delivery of chimeric phi29 pRNA/siRNA nanoparticles to multiple tumor cells.
Li L; Liu J; Diao Z; Shu D; Guo P; Shen G
Mol Biosyst; 2009 Nov; 5(11):1361-8. PubMed ID: 19823753
[TBL] [Abstract][Full Text] [Related]
3. Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers.
Tarapore P; Shu Y; Guo P; Ho SM
Mol Ther; 2011 Feb; 19(2):386-94. PubMed ID: 21063391
[TBL] [Abstract][Full Text] [Related]
4. Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene.
Qiu C; Peng WK; Shi F; Zhang T
Genet Mol Res; 2012 Sep; 11(3):3236-45. PubMed ID: 23079817
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.
Abdelmawla S; Guo S; Zhang L; Pulukuri SM; Patankar P; Conley P; Trebley J; Guo P; Li QX
Mol Ther; 2011 Jul; 19(7):1312-22. PubMed ID: 21468004
[TBL] [Abstract][Full Text] [Related]
6. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells.
Shu Y; Shu D; Haque F; Guo P
Nat Protoc; 2013 Sep; 8(9):1635-59. PubMed ID: 23928498
[TBL] [Abstract][Full Text] [Related]
8. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
Guo S; Tschammer N; Mohammed S; Guo P
Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
[TBL] [Abstract][Full Text] [Related]
9. Modular assembly of chimeric phi29 packaging RNAs that support DNA packaging.
Fang Y; Shu D; Xiao F; Guo P; Qin PZ
Biochem Biophys Res Commun; 2008 Aug; 372(4):589-94. PubMed ID: 18514064
[TBL] [Abstract][Full Text] [Related]
10. Assembly of multifunctional phi29 pRNA nanoparticles for specific delivery of siRNA and other therapeutics to targeted cells.
Shu Y; Cinier M; Shu D; Guo P
Methods; 2011 Jun; 54(2):204-14. PubMed ID: 21320601
[TBL] [Abstract][Full Text] [Related]
11. Grouping of ferritin and gold nanoparticles conjugated to pRNA of the phage phi29 DNA-packaging motor.
Moll WD; Guo P
J Nanosci Nanotechnol; 2007 Sep; 7(9):3257-67. PubMed ID: 18019159
[TBL] [Abstract][Full Text] [Related]
12. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.
Guo S; Huang F; Guo P
Gene Ther; 2006 May; 13(10):814-20. PubMed ID: 16482206
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, conjugation, and labeling of multifunctional pRNA nanoparticles for specific delivery of siRNA, drugs, and other therapeutics to target cells.
Guo P; Shu Y; Binzel D; Cinier M
Methods Mol Biol; 2012; 928():197-219. PubMed ID: 22956144
[TBL] [Abstract][Full Text] [Related]
14. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model.
Lee TJ; Haque F; Shu D; Yoo JY; Li H; Yokel RA; Horbinski C; Kim TH; Kim SH; Kwon CH; Nakano I; Kaur B; Guo P; Croce CM
Oncotarget; 2015 Jun; 6(17):14766-76. PubMed ID: 25885522
[TBL] [Abstract][Full Text] [Related]
15. Chemical modification patterns of active and inactive as well as procapsid-bound and unbound DNA-packaging RNAof bacterial virus Phi29.
Zhang C; Trottier M; Chen C; Guo P
Virology; 2001 Mar; 281(2):281-93. PubMed ID: 11277700
[TBL] [Abstract][Full Text] [Related]
16. RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
Guo P
J Nanosci Nanotechnol; 2005 Dec; 5(12):1964-82. PubMed ID: 16430131
[TBL] [Abstract][Full Text] [Related]
17. Chemically Synthesized, Self-Assembling Small Interfering RNA-Prohead RNA Molecules Trigger Dicer-Independent Gene Silencing.
Hill AC; van Leeuwen D; Schlösser V; Behera A; Mateescu B; Hall J
Chemistry; 2022 Feb; 28(8):e202103995. PubMed ID: 34879171
[TBL] [Abstract][Full Text] [Related]
18. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
19. The procapsid binding domain of phi29 packaging RNA has a modular architecture and requires 2'-hydroxyl groups in packaging RNA interaction.
Fang Y; Cai Q; Qin PZ
Biochemistry; 2005 Jul; 44(26):9348-58. PubMed ID: 15982001
[TBL] [Abstract][Full Text] [Related]
20. Dual-channel single-molecule fluorescence resonance energy transfer to establish distance parameters for RNA nanoparticles.
Shu D; Zhang H; Petrenko R; Meller J; Guo P
ACS Nano; 2010 Nov; 4(11):6843-53. PubMed ID: 20954698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
